Sensorium Therapeutics

Psychedelics startups are being increasingly funded by private placements these days. This time, the biotech company led by expert researchers, clinicians and drug developers from Massachusetts General Hospital and Harvard Medical School, Sensorium Therapeutics, has closed a $30 million Series...